Acridine Carboxamide
Small moleculeexperimental
DACA is Deferred Action for Childhood Arrivals, a United States immigration policy that began in 2012. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 1999 (NCT00004151)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Topoisomerase I/IIINHIBITOR
Topoisomerase I/II inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDACA (disambiguation) ↗
Also known as
- acridine carboxamide
- acridine carboxamide
- acridine carboxamide
- daca
- daca
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004937 | Phase 2 | Oct 1, 1999 | European Organisation for Research and Treatment of Cancer, University of Glasgow |
| NCT00004151 | Phase 2 | Sep 1, 1999 | European Organisation for Research and Treatment of Cancer, Haemato-Onkologische Praxis und Tagesklinik |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Organisation for Research and Treatment of Cancer | Academic/Hospital | 2 | 2 | 1 | 1999 |
| Haemato-Onkologische Praxis und Tagesklinik | Academic/Hospital | 1 | 0 | 1 | 1999 |
| University of Glasgow | Academic/Hospital | 1 | 0 | 1 | 1999 |
3 organizations
Page 1 / 1